➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LITHOBID

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Lithobid

Subscribe to access the full database, or Try it Free
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00183443 ↗	Treatment of Mania Symptoms With Drug Therapy	Completed	National Institute of Mental Health (NIMH)	Phase 3	2005-02-01	This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00183443 ↗	Treatment of Mania Symptoms With Drug Therapy	Completed	Palo Alto Veterans Institute for Research	Phase 3	2005-02-01	This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00601536 ↗	Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions	Completed	Roxane Laboratories	N/A	2003-04-01	The objective of this study was the bioequivalence of a Roxane lithium carbonate 300 mg extended release tablet formulation compared to Solvay's Lithobid 300 mg extended release tablet under fasting conditions using a single-dose, randomized, 2 treatment, 2-period, 2-sequence crossover design.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Lithobid

Condition Name

Chart
Table

Condition Name for Lithobid
Intervention	Trials
Bipolar Disorder	4
Bipolar Affective Disorder	1
Asthma: [Nos] or [Attack]	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Lithobid
Intervention	Trials
Bipolar Disorder	5
Depressive Disorder	3
Depression	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Lithobid

Trials by Country

Map
Table

Trials by Country for Lithobid
Location	Trials
United States	14
Sweden	2
Norway	1
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Lithobid
Location	Trials
Texas	2
Pennsylvania	2
California	2
Minnesota	1
New Mexico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Lithobid

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Lithobid
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Lithobid
Clinical Trial Phase	Trials
Completed	4
Unknown status	1
Enrolling by invitation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lithobid

Sponsor Name

Chart
Table

Sponsor Name for Lithobid
Sponsor	Trials
Roxane Laboratories	2
Örebro County Council	1
Montana State University	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Lithobid
Sponsor	Trials
Other	13
Industry	2
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Boehringer Ingelheim

Dow

Colorcon

Johnson and Johnson

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.